Department of Pharmacotherapy,, University of North Texas Health Science Center, College of Pharmacy, Fort Worth, TX, USA.
Department of Health Behavior and Health Systems, University of North Texas Health Science Center, School of Public Health, Fort Worth, TX, USA.
BMC Geriatr. 2020 Dec 3;20(1):523. doi: 10.1186/s12877-020-01924-x.
About 50% of all hospitalized fragility fracture cases in older Americans are hip fractures. Approximately 3/4 of fracture-related costs in the USA are attributable to hip fractures, and these are mostly covered by Medicare. Hip fracture patients with dementia, including Alzheimer's disease, have worse health outcomes including longer hospital length of stay (LOS) and charges. LOS and hospital charges for dementia patients are usually higher than for those without dementia. Research describing LOS and acute care charges for hip fractures has mostly focused on these outcomes in trauma patients without a known pre-admission diagnosis of osteoporosis (OP). Lack of documented diagnosis put patients at risk of not having an appropriate treatment plan for OP. Whether having a diagnosis of OP would have an effect on hospital outcomes in dementia patients has not been explored. We aim to investigate whether having a diagnosis of OP, dementia, or both has an effect on LOS and hospital charges. In addition, we also report prevalence of common comorbidities in the study population and their effects on hospital outcomes.
We conducted a cross-sectional analysis of claims data (2012-2013) for 2175 Medicare beneficiaries (≥65 years) in the USA.
Compared to those without OP or dementia, patients with demenia only had a shorter LOS (by 5%; P = .04). Median LOS was 6 days (interquartile range [IQR]: 5-7), and the median hospital charges were $45,100 (IQR: 31,500 - 65,600). In general, White patients had a shorter LOS (by 7%), and those with CHF and ischemic heart disease (IHD) had longer LOS (by 7 and 4%, respectively). Hospital charges were 6% lower for women, and 16% lower for White patients.
This is the first study evaluating LOS in dementia in the context of hip fracture which also disagrees with previous reporting about longer LOS in dementia patients. Patients with CHF and IHD remains at high risk for longer LOS regardless of their diagnosis of dementia or OP.
在美国,大约有 50%的老年脆性骨折住院患者是髋部骨折。在美国,大约有四分之三的骨折相关费用归因于髋部骨折,而这些费用主要由医疗保险(Medicare)支付。患有痴呆症(包括阿尔茨海默病)的髋部骨折患者的健康状况更差,包括住院时间(LOS)更长和费用更高。痴呆症患者的 LOS 和住院费用通常高于非痴呆症患者。描述髋部骨折 LOS 和急性护理费用的研究主要集中在没有已知的骨质疏松症(OP)入院前诊断的创伤患者的这些结果上。缺乏记录的诊断使患者面临 OP 治疗计划不当的风险。是否存在 OP 诊断是否会对痴呆症患者的医院结果产生影响尚未得到探索。我们旨在研究是否存在 OP、痴呆症或两者都对 LOS 和医院费用有影响。此外,我们还报告了研究人群中常见合并症的患病率及其对医院结果的影响。
我们对美国 2175 名医疗保险受益人(≥65 岁)的索赔数据(2012-2013 年)进行了横断面分析。
与没有 OP 或痴呆症的患者相比,只有痴呆症患者的 LOS 更短(短 5%;P = 0.04)。中位 LOS 为 6 天(四分位距 [IQR]:5-7),中位住院费用为 45100 美元(IQR:31500-65600)。一般来说,白人患者的 LOS 更短(短 7%),而充血性心力衰竭(CHF)和缺血性心脏病(IHD)患者的 LOS 更长(分别长 7%和 4%)。女性的住院费用低 6%,白人患者低 16%。
这是第一项评估髋部骨折背景下痴呆症 LOS 的研究,与之前关于痴呆症患者 LOS 更长的报告也不一致。无论是否患有痴呆症或 OP,CHF 和 IHD 患者的 LOS 仍处于较高风险。